After HFD loading, peroxisome proliferator-activated receptor-alpha/beta/gamma (PPAR-α/β/δ) transcriptional activation induces the fat-metabolizing enzyme CD36 and suppresses the onset of the heart failure in a pathological model [[10], [11], [12]]. Here, PPARA is linked to heart failure.